Cwm, LLC Codexis, Inc. Transaction History

Cwm, LLC

$33.3 Billion
Q3 2025

A detailed history of Cwm, LLC transactions in Codexis, Inc. stock. As of the latest transaction made, Cwm, LLC holds 4,293 shares of CDXS stock, worth $9,702. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,293

Previous 5,768 25.57%

Holding current value

$9,702

Previous $14,000 28.57%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 15, 2025	SELL	$2.35 - $3.33 $3,466 - $4,911	-1,475 Reduced 25.57%	4,293 $10,000
Q2 2025 Jul 25, 2025	BUY	$1.97 - $2.64 $2,801 - $3,754	1,422 Added 32.72%	5,768 $14,000
Q1 2025 May 01, 2025	BUY	$2.53 - $5.43 $862 - $1,851	341 Added 8.51%	4,346 $12,000
Q4 2024 Feb 04, 2025	BUY	$2.91 - $5.81 $293 - $586	101 Added 2.59%	4,005 $19,000
Q3 2024 Oct 08, 2024	SELL	$2.62 - $3.71 $3,665 - $5,190	-1,399 Reduced 26.38%	3,904 $12,000
Q2 2024 Jul 09, 2024	BUY	$2.65 - $3.92 $8,252 - $12,206	3,114 Added 142.26%	5,303 $16,000
Q1 2024 Apr 05, 2024	BUY	$2.59 - $4.65 $1,414 - $2,538	546 Added 33.23%	2,189 $8,000
Q3 2023 Oct 11, 2023	SELL	$1.5 - $3.75 $2,578 - $6,446	-1,719 Reduced 51.13%	1,643 $3,000
Q2 2023 Aug 03, 2023	BUY	$2.21 - $4.43 $7,202 - $14,437	3,259 Added 3164.08%	3,362 $9,000
Q1 2023 Apr 28, 2023	SELL	$3.81 - $6.76 $887 - $1,575	-233 Reduced 69.35%	103 $0
Q4 2022 Feb 01, 2023	BUY	$4.26 - $6.84 $834 - $1,340	196 Added 140.0%	336 $2,000
Q3 2022 Oct 27, 2022	BUY	$6.06 - $12.86 $557 - $1,183	92 Added 191.67%	140 $1,000
Q2 2022 Jul 28, 2022	BUY	$8.35 - $21.89 $83 - $218	10 Added 26.32%	48 $1,000
Q1 2022 Apr 21, 2022	BUY	$16.97 - $31.93 $644 - $1,213	38 New	38 $1,000

Others Institutions Holding CDXS

# of Institutions

129

Shares Held

66.7M

Call Options Held

25.8K

Put Options Held

20K

View Full List

About CODEXIS, INC.

Ticker CDXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,494,100
Market Cap $148M
Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...

More about CDXS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account